Middle East

Pharmaceutical Export to the Middle East

The GCC and wider Middle East combine advanced private healthcare infrastructure with growing public-sector procurement demand. The Indian Pharma supplies WHO-GMP compliant medicines to distributors, hospitals, and procurement agencies across this region.

Countries We Export To Across the Middle East

GCC (Gulf Cooperation Council)
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman

Wider Middle East
Jordan, Iraq, Lebanon, Israel, Palestine, Yemen, Syria

Products in Highest Demand

Category Coverage
Oncology & immunotherapy biologics Private and public-sector cancer treatment
Autoimmune disease biologics Rheumatology and gastroenterology treatment demand
Rare disease medicines Named-patient import for specialty conditions
Metabolic disease therapies High regional diabetes prevalence

Why Middle East Buyers Source from India

Factor Detail
Stringent documentation Aligned with GCC registration requirements
Cold chain reliability Built for biologics-heavy regional demand
Competitive pricing Relative to originator-brand and European alternatives
Manufacturer flexibility 150+ accredited facilities matched to country-specific needs

FAQs

Which Middle East countries do you export to?
We export across the GCC — UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman — along with the wider Middle East including Jordan and Iraq, with additional markets confirmed on inquiry.

Do you support both private hospital and government tender procurement?
Yes, we work with both private hospital networks and government health authorities across the region.

Is documentation matched to GCC-specific registration standards?
Yes, we confirm the exact certification and documentation required for each GCC country before shipment.

Can rare disease medicines be sourced for private hospitals?
Yes, including through named-patient import pathways where local registration isn't yet established.

What cold chain standards apply to biologics shipped to this region?
All temperature-sensitive biologics ship under GDP-compliant cold chain, validated across the required storage range for each specific product.